Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
2023
María T Rivera-García, Silvia L. Cruz
8 citations
Since the dawn of civilization, ancient cultures have utilized hallucinogens from plants and fungi in the context of religious and healing practices. Recently, their use has expanded to other cultures. Hallucinogens are natural or synthetic substances that alter the perception of reality at nontoxic doses, producing intense psychological and physiological effects. The initial research on...
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
2023
Miguel I Paz-Ramos, Silvia L. Cruz, Valeria Violante-Soria
This review focuses on the effects and mechanisms of action of amphetamine-type stimulants (ATS) and their adverse effects on the cardiovascular, nervous, and immune systems. ATS include amphetamine (AMPH), methamphetamine (METH, "crystalmeth," or "ice"), methylenedioxymethamphetamine (MDMA, "ecstasy," or "Molly"), MDMA derivatives (e.g., methylenedioxyamphetamine [MDA] and...
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
2023
Ana Canseco-Alba, Gabriela Rodríguez-Manzo
The consumption of Cannabis sativa plant, known as marijuana in the Western world, for different purposes (therapeutic, intoxicating, and spiritual) due to its psychoactive effects, can be traced back to ancient times. Cannabis is the most used illicit drug worldwide; however, its legal status is changing rapidly. Cannabis regulation will allow a better understanding of its effects as a misused...
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
2018
Rodrigo Pérez-Esparza
Current alternatives for the treatment of major depressive disorder lack efficacy and have a delayed onset of action. Recently, the glutamatergic neurotransmission system has been noted to play an important role in the pathophysiology of this disorder. Ever since the first report of the antidepressant effects of the N-methyl-D-aspartate receptor antagonist, ketamine, research has been...